AARD News

AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

AARD 2-WEEK DEADLINE ALERT: Aardvark Therapeutics Investors with Substantial Losses Have Opportunity to Lead Shareholder Class Action Lawsuit Before October 13, 2026 Lead Plaintiff Deadline

DEADLINE ALERT for UWMC, HDB, SMPL, and AARD: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

AARD DEADLINE: SueWallSt Reminds Aardvark Therapeutics, Inc. Investors of Upcoming Securities Class Action Deadline

Portnoy Law Firm Announces Class Action on Behalf of Aardvark Therapeutics, Inc. Investors

Bronstein, Gewirtz & Grossman LLC Urges Aardvark Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Aardvark Therapeutics, Inc. (AARD) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before October 13, 2026

Recover Investment Losses: Class Action Initiated Against Aardvark Therapeutics, Inc. (AARD)

Shareholders of Aardvark Therapeutics, Inc. (AARD): Protect Your Rights Before October 13, 2026 - Contact Levi & Korsinsky

AARD Deadline: AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit